The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan
Journal
International Journal of Medical Sciences
Journal Volume
11
Journal Issue
4
Pages
381-388
Date Issued
2014
Author(s)
Lin T.-H.
Chuang S.-Y.
Chu C.-Y.
Lee W.-H.
Hsu P.-C.
Su H.-M.
Li Y.-H.
Fang C.-C.
Wang K.-Y.
Tseng W.-K.
Ueng K.-C.
Hsieh I.-C.
Huang L.-C.
Wang C.-H.
Pan W.-H.
Yeh H.-I.
Yin W.-H.
Chen J.-W.
Abstract
Background: Patients with chronic kidney disease (CKD) is a very high risk cardiovascular disease population and should be treated aggressively. We investigated lipid management in CKD patients with atherosclerosis in Taiwan. Methods: 3057 patients were enrolled in a multi-center study (T-SPARCLE). Lipid goal are defined as total cholesterol (TC) < 160mg/dl, low-density lipoprotein (LDL) <100 mg/dl, high-density lipoprotein (HDL) > 40 mg/dl in men, HDL > 50 mg/dl in women, non-HDL cholesterol < 130mg/dl, and triglyceride < 150 mg/dl. Results: Compared with those without CKD (n=2239), patients with CKD (n=818) had more co-morbidities (hypertension, glucose intolerance, stroke and heart failure) and lower HDL but higher triglyceride levels. Overall 2168 (70.5%) patients received lipid-lowering agents. There was similar equivalent statin potency between CKD and non-CKD groups. The goal attainment is lower in HDL and TG in the CKD group as compared with non-CKD subjects (47.1 vs. 51.9% and 63.2 vs. 68.9% respectively, both p < 0.02). Analysis of sex and CKD interaction on goals attainment showed female CKD subjects had lower non-HDL and TG goals attainment compared with non-CKD males (both p < 0.019). Conclusion: Although presenting with more comorbidities, the CKD population had suboptimal lipid goal attainment rate as compared with the non-CKD population. Further efforts may be required for better lipid control especially on the female CKD subjects. ? Ivyspring International Publisher.
Subjects
Atherosclerosis; Chronic kidney disease; Goal; Lipid
SDGs
Other Subjects
acetylsalicylic acid; acipimox; alpha adrenergic receptor blocking agent; angiotensin receptor antagonist; antilipemic agent; calcium channel blocking agent; cholesterol; clopidogrel; colestyramine; dipeptidyl carboxypeptidase inhibitor; diuretic agent; ezetimibe; fibric acid derivative; high density lipoprotein cholesterol; hydroxymethylglutaryl coenzyme A reductase inhibitor; low density lipoprotein cholesterol; triacylglycerol; aged; article; atherosclerosis; cerebrovascular accident; cholesterol blood level; chronic kidney disease; comorbidity; controlled study; disease control; drug use; dyslipidemia; female; glucose intolerance; goal attainment; heart failure; human; hypertension; major clinical study; male; sex; Taiwan; triacylglycerol blood level; atherosclerosis.; chronic kidney disease; goal; lipid; Atherosclerosis; Cross-Sectional Studies; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Multivariate Analysis; Renal Insufficiency, Chronic; Taiwan; Triglycerides
Publisher
Ivyspring International Publisher
Type
journal article